NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 263 filers reported holding NEOGENOMICS INC in Q2 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $331,018 | +86.4% | 26,912 | +163.8% | 0.00% | -66.7% |
Q1 2023 | $177,582 | +51.0% | 10,200 | -19.9% | 0.00% | +50.0% |
Q4 2022 | $117,616 | -90.4% | 12,729 | -87.4% | 0.00% | -93.9% |
Q1 2022 | $1,230,000 | +44.5% | 101,264 | +127.6% | 0.03% | -35.3% |
Q3 2019 | $851,000 | -46.7% | 44,500 | -38.9% | 0.05% | -70.9% |
Q2 2019 | $1,597,000 | – | 72,800 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 1,291,019 | $22,477 | 12.11% |
Greenhouse Funds LLLP | 2,930,014 | $51,011,544 | 4.27% |
First Light Asset Management, LLC | 2,698,958 | $46,988,859 | 4.23% |
PERKINS CAPITAL MANAGEMENT INC | 197,000 | $3,430 | 3.23% |
Altium Capital Management LP | 240,000 | $4,178,400 | 2.32% |
FORMULA GROWTH LTD | 280,690 | $4,886,813 | 1.57% |
BOULDER HILL CAPITAL MANAGEMENT LP | 101,065 | $1,759,542 | 1.42% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,374,783 | $23,934,972 | 1.41% |
EMERALD ADVISERS, LLC | 1,669,324 | $29,062,931 | 1.39% |
Lisanti Capital Growth, LLC | 528,235 | $9,196,571 | 1.28% |